GEMMABio is a therapeutics company focused on advancing research and global access to life-changing advanced therapies for those living with rare diseases. The company will provide research and product development functions to bring gene therapy discoveries from the bench to the bedside faster and affordably.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/26/24 | $34,000,000 | Seed |
Bioluminescence Ventures Double Point Ventures Earlybird Savanne Life Sciences | undisclosed |
